USPTO trademark

MYTEVARX

Under examinationUSPTOWord markClass 9Class 35Class 42Class 44

"MYTEVARX" is a word mark owned by Teva Pharmaceutical Industries Ltd., filed at the USPTO on October 5, 2026. It is under examination and covers classes 9, 35, 42 and 44.

Official USPTO record
MYTEVARX trademark as filed
As filed with the USPTO
Status
Under examination
Since October 5, 2026
Filed
October 5, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50144125
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns MYTEVARX

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services MYTEVARX is filed for, grouped by Nice class.

  • Downloadable software for telehealth and telemedicine operations; downloadable computer software for prescribing, ordering, filling, managing, and providing information regarding prescription usage, dosage and directions; downloadable software for enabling patients to review details about medications and receive automated warnings of potential adverse interactions of medications; downloadable software for enabling patients to request, receive, track shipment of, and manage prescriptions and orders for pharmaceuticals; downloadable software for enabling patients to access general medical, health, and wellness information and advice.

  • Pharmacy services; online retail pharmacy services; mail order pharmacy services; online retail store services featuring pharmaceuticals; online retail pharmacy services for the ordering, purchase, delivery of pharmaceuticals, and processing prescription orders; Appointment scheduling services in the field of medicine and telehealth

  • Platform as a service featuring computer software to permit users to identify, request and receive pharmacy products

  • Providing information in the fields of pharmaceuticals, healthcare, medicines, vaccines, healthy lifestyle, health conditions, health awareness and treatment options; medical information services, namely, providing information related to healthcare, diseases, disorders, and treatment options; online information services, namely, providing a website related to healthcare, health awareness, medicines, vaccines, diseases, disorders, and treatment options. Healthcare services; medical services; telemedicine services; arranging and providing medical information services relating to pharmaceuticals, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About MYTEVARX

Who owns the trademark "MYTEVARX"?

The USPTO trademark "MYTEVARX" (application 50144125) is owned by Teva Pharmaceutical Industries Ltd.

What is the status of "MYTEVARX"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MYTEVARX and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a1115a-76c8-7249-b016-0b7e867d1fd0
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a1115a-76c8-7249-b016-0b7e867d1fd0",
  "object": "trademark",
  "mark_text": "MYTEVARX",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50144125",
  "filing_date": "2026-10-05",
  "nice_classes": [
    9,
    35,
    42,
    44
  ],
  "owners": [
    {
      "name": "Teva Pharmaceutical Industries Ltd.",
      "entity_id": "ent_019ebbc5-6f32-7092-a649-5aaa7b712e21"
    }
  ]
}